Cargando…
SUN-LB054 Cilengitide Reverts Thyroid Hormones Effects in Bexarotene Treatment of Breast Cancer Cells
Bexarotene (Bex) is an oral retinoid-X-receptor agonist that is effective for the treatment of early and advanced-stage in cutaneous T cell lymphoma. There are ongoing clinical trials to determine its role in both breast cancer treatment and prevention. Unfortunately, hypothyroidism is recognized as...
Autores principales: | Díaz Albuja, Johanna, Debernardi, María, Cayrol, Florencia, Rosemblit, Cinthia, Cremaschi, Graciela, Díaz Flaqué, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553160/ http://dx.doi.org/10.1210/js.2019-SUN-LB054 |
Ejemplares similares
-
ODP560 Thyroid Hormones membrane receptor, Integrin αvβ3, as a potential prognostic marker of chemotherapy response in breast cancer
por: Haedo, Mateo Campos, et al.
Publicado: (2022) -
Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells
por: Díaz Flaqué, María Celeste, et al.
Publicado: (2019) -
MON-LB054 Activity of Prolactin Receptor Antagonist-Rapamycin Conjugate in Glioblastoma Multiform
por: Alkharusi, Amira, et al.
Publicado: (2019) -
Non-genomic Actions of Thyroid Hormones Regulate the Growth and Angiogenesis of T Cell Lymphomas
por: Cayrol, Florencia, et al.
Publicado: (2019) -
Editorial: Hormones and receptors in breast cancer
por: Rosemblit, Cinthia, et al.
Publicado: (2023)